Juan Jaen
About Juan Jaen
President of Arcus Biosciences
Juan Jaen serves as the President of Arcus Biosciences, a company he co-founded in 2015. Under his leadership, Arcus Biosciences focuses on innovative cancer immunotherapy treatments. Jaen’s extensive experience in drug discovery and development plays a crucial role in guiding the company's scientific advancements.
Co-founder of Flexus Biosciences
In addition to his role at Arcus Biosciences, Juan Jaen co-founded Flexus Biosciences. This company has gained recognition for its work in developing immuno-oncology therapeutics. Jaen’s strategic vision and scientific expertise have been instrumental in establishing Flexus Biosciences as a key player in the biopharmaceutical industry.
Chief Scientific Officer at ChemoCentryx
Juan Jaen served as the Chief Scientific Officer and Senior Vice President of Drug Discovery at ChemoCentryx for seven years. During his tenure, he led the discovery and progression into the clinic of eight novel immunology drug candidates. His contributions significantly advanced the company’s research and development efforts.
Career at Amgen, Tularik, and Parke-Davis
Over his extensive career, Juan Jaen has held various roles at notable companies including Amgen, Tularik, and Parke-Davis/Warner-Lambert. His diverse experiences at these organizations have enriched his expertise in the drug discovery and development sector.
Patent Inventor and Drug Development
Juan Jaen is an inventor on 50 patents and has helped advance over 20 novel molecules into clinical development across a range of medical indications. His work spans more than 30 years, during which he has been deeply involved in all aspects of drug discovery and development.